首页 | 本学科首页   官方微博 | 高级检索  
检索        

以大剂量环磷酰胺为主治疗上腔静脉综合征临床分析
引用本文:牟玲,陈为志.以大剂量环磷酰胺为主治疗上腔静脉综合征临床分析[J].四川肿瘤防治,2000,13(3):173-175.
作者姓名:牟玲  陈为志
作者单位:山东省日照市人民医院,日照
摘    要:目的:采用以大剂量环磷酰胺(HD-CTX)主为联合化疗方案治疗由恶性肿瘤引起的上腔静脉综合征(SVCS)。方法:SVCS32例,其中中肺癌与胸腺癌15例选用CAP方案,恶性淋巴瘤6例选用ABCOP方案。结果:恶性淋巴瘤CR66.67%(4/6),PR33.33%(2/6)。SCLS CR28.57%(4/14),PR35.71%(5/14),NC28.57%(4/14),PD7.14%(1/14)

关 键 词:上腔静脉综合征  环磷酰胺  治疗  纵隔肿瘤

Clinical analysis of high-dose cytoxan in treating patient with SVCS
MU Ling,CHEN Wei-zhi,LIU Hai-rong,et alRizhao People's Hospital,Rizhao.Clinical analysis of high-dose cytoxan in treating patient with SVCS[J].Sichuan Journal of Cancer Control,2000,13(3):173-175.
Authors:MU Ling  CHEN Wei-zhi  LIU Hai-rong  Rizhao People's Hospital  Rizhao
Institution:MU Ling,CHEN Wei-zhi,LIU Hai-rong,et alRizhao People's Hospital,Rizhao 276826
Abstract:Objective:To study the efficacy of high-dose cytoxan (CTX) based combined chemotherapy in treating the patients with superior vena cava syndrom (SVCS)caused by malignant tumors.Methods:Patients with lung cancer or malignant thymoma were treated with CAP regimen.Maliglant lymphoma patients were treated with ABCOP regimen.Rusults:The response rates were:lymphoma CR 66.67%(4/6),PR 33.33%(2/6);SCLC CR 28.57%(4/14),PR 35.71%(5/14),NC 28.57%(4/14),PD 7.14%(1/14),NSCLC CR 9%(1/11),PR 36.36%(4/11),NC 36.36%(4/11),PD 18.18%(2/11) malignant thymoma NC(1/1).The response rate of SVCS in two days was 21.9%(7/32) ;43.8% (14/32) from three to five days;18.8% (6/32) from 5 to 7 days;15.6% (5/32) beyond seven days.Conclusion:The high-dose CTX was effective and well tolerated in treating the cancer patients with SVCS.
Keywords:SVCS  CTX  Chemotherapy
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号